Check out our most popular compounded medications! Get Started
Dimercaptosuccinic Acid 100 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. These capsules are used in the treatment of Wilson's Disease, Lead Poisoning, Mercury Poisoning, Arsenic Poisoning, and Cadmium Poisoning.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dimercaptosuccinic Acid 100 mg Slow Release Capsules is a specialized medication designed to treat a variety of conditions, primarily those involving heavy metal poisoning such as lead and mercury, as well as Wilson's disease, a rare genetic disorder that leads to excessive copper accumulation in the body. This medication functions as a chelating agent, effectively binding to heavy metals in the body and aiding in their removal.
This particular formulation is encapsulated within Methocel E4M, a controlled-release polymer. This innovative design allows for the gradual release of the active ingredient over an extended period of time. The slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
By allowing for a more gradual release of the medication into the body, the slow release capsules help to minimize the risk of side effects and maintain more consistent levels of the medication in the body. This makes Dimercaptosuccinic Acid 100 mg Slow Release Capsules a appropriate treatment option for a variety of disease states.
As with any medication, it is crucial to follow the instructions provided by your healthcare provider when taking Dimercaptosuccinic Acid 100 mg Slow Release Capsules. If you have any questions or concerns about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
Dimercaptosuccinic Acid 100 mg Slow Release Capsules are a specialized formulation designed to provide a controlled and prolonged release of the active ingredient. This is achieved through the use of Methocel E4M, a type of controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled release profile.
These capsules are primarily used in the treatment of lead poisoning, Wilson's disease, and cystinuria. The active ingredient, Dimercaptosuccinic Acid, works by binding to metals and other substances in the body, facilitating their excretion in the urine. However, this medication may also be used to treat other conditions as determined by a healthcare provider.
It's important for patients to inform their healthcare provider of all medications, supplements, and herbal products they are currently taking before starting this medication. Additionally, any allergies or medical conditions that may affect the use of this medication should also be disclosed. Pregnant or breastfeeding individuals should not take Dimercaptosuccinic Acid 100 mg Slow Release Capsules.
Common side effects of this medication include nausea, vomiting, diarrhea, and abdominal pain. More serious side effects may include allergic reactions, kidney damage, and liver damage. If any of these side effects are experienced, patients should contact their healthcare provider immediately.
For any further questions or concerns regarding the use of Dimercaptosuccinic Acid 100 mg Slow Release Capsules, please consult with your healthcare provider.
Dimercaptosuccinic Acid 100 mg Slow Release Capsules are a specialized formulation designed to treat a range of conditions such as lead poisoning, Wilson's disease, and cystinuria. The capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The active ingredient, Dimercaptosuccinic Acid, functions by binding to heavy metals like lead, aiding in their removal from the body. It also helps to decrease the amount of cystine in the urine, a key contributor to kidney stones in patients with cystinuria.
When using Dimercaptosuccinic Acid 100 mg Slow Release Capsules, it is crucial to follow the prescribed dosage from your healthcare provider. The capsules should be taken with food and ample water to facilitate proper absorption. Consistency in the timing of medication intake is also important to maintain a steady release of the medication.
If you have any queries regarding Dimercaptosuccinic Acid 100 mg Slow Release Capsules or its mechanism of action, please do not hesitate to contact us.
Dimercaptosuccinic Acid 100 mg Slow Release Capsules are a versatile treatment option for a variety of conditions. These capsules are formulated with Methocel E4M, a controlled-release polymer, which allows for the gradual release of the active ingredient over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules can be used to treat heavy metal poisoning, including exposure to copper, iron, and zinc. The capsules can be used to manage certain types of kidney stones, specifically cystine stones.
Dimercaptosuccinic Acid 100 mg Slow Release Capsules can also be beneficial in treating certain types of anemia, such as sideroblastic anemia. They can be used to manage certain liver diseases, including biliary cirrhosis. Furthermore, these capsules can be used to treat certain types of kidney disease, such as Fanconi Syndrome.
If you have any questions about the use of Dimercaptosuccinic Acid 100 mg Slow Release Capsules for any of these conditions, please do not hesitate to reach out for more information. It is important to consult with a healthcare professional before starting any new medication regimen.
Dimercaptosuccinic Acid 100 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation to ensure that the medication is released gradually over a prolonged period, offering sustained therapeutic effects.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
The dosing frequency of Dimercaptosuccinic Acid 100 mg Slow Release Capsules is typically less than that of regular medications due to its slow-release formulation. However, the exact frequency will depend on your doctor's prescription.
'Improved patient compliance' means that patients are more likely to take their medication as prescribed. This is because the slow-release formulation reduces the frequency of dosing, making it more convenient for patients.
No, the slow-release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the medication over an extended period.
No, the capsule should not be opened or crushed. Doing so can interfere with the controlled-release mechanism and may lead to a sudden release of the medication, which can be harmful.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.
Whether you can take this medication with food or not will depend on your doctor's instructions. Some medications may need to be taken on an empty stomach while others can be taken with food. Always follow your doctor's advice.
In case of an overdose, seek immediate medical attention. Symptoms of an overdose may vary depending on the medication and the amount taken, but they can include nausea, vomiting, and severe dizziness.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
